Do you offer maintenance rituximab in transplant ineligible patients with mantle cell lymphoma?
1 Answers
Mednet Member
Medical Oncology · Brigham and Women's Hospital
The data on the role of rituximab maintenance therapy in transplant ineligible patients with mantle cell lymphoma are not straightforward to interpret. The most often cited experience (Kluin-Nelemans, et al., PMID 22873532) is a complicated study with two randomizations: induction therapy was either...